CVT-E002 stimulates the immune system and extends the life span of mice bearing a tumor of viral origin

Journal of the Society for Integrative Oncology

Volumn 7, Issue 4, 2009, Pages 127-136

  Miller, Sandra C ^a   Delorme, Danielle ^a   Shan, Jacqueline J ^b  

^a MCGILL UNIVERSITY   (Canada)

^b CV Technologies Inc   (Canada)

Author keywords

Cancer; Ginseng; Mice; Natural killer cells

Indexed keywords

CVT E 002; GINSENG EXTRACT; PANAX QUINQUEFOLIUS EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW; CANCER SURVIVAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; ERYTHROLEUKEMIA; GINSENG; GRANULOCYTE; IMMUNOSTIMULATION; IMMUNOTHERAPY; IN VIVO STUDY; LIFESPAN; MALE; MONOCYTE; MORNING DOSAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANAX QUINQUEFOLIUS; PLANT ROOT; SPLEEN; TUMOR CELL;

ANIMALS; BONE MARROW; BONE MARROW CELLS; FRIEND MURINE LEUKEMIA VIRUS; KILLER CELLS, NATURAL; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, EXPERIMENTAL; MALE; MICE; MICE, INBRED DBA; MONOCYTES, ACTIVATED KILLER; PANAX; PLANT EXTRACTS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; TUMOR CELLS, CULTURED;

EID: 76649130942     PISSN: 1715894X     EISSN: None     Source Type: Journal    
DOI: 10.2310/7200.2009.0013     Document Type: Article

References (42)

1. Nowinski RC. Immune response to leukemia viruses in mice. In: Notkins AL, editor. Viral immunology and immunopathology. New York: Academic Press; 1975. p. 237-60.
2. Freedman SO. Clinical immunology of the lymphoreticular system. In: Freedman SO, editor. Clinical immunology. New York: Harper & Row; 1971. p. 372-418.
3. Klein E, Montovani A. Action of natural killer cells and macrophages in cancer. Curr Opin Immunol 1993; 5: 714-8.
4. Kawarada Y, Ganss R, Garbi N, et al. NK- and CD8+ T-cell mediated readication of established tumors by peritumoral injection of CpG-containing oligonucleotide. J Immunol 2001; 167: 5247-53.
5. Rayburn ER, Wang W, Zhang Z, et al. Experimental therapy of prostate cancer with an immunomodulatory oligonucleotide: effects on tumor growth, apotosis, proliferation and potentiation of chemotherapy. Prostate 2006; 66: 1653-63.
6. Wang M, Guilbert LJ, Ling L, et al. Immunomodulating activity of CVT-E002, a proprietary extract from North American ginseng ( Panax quinquefolius ). J Pharm Pharmacol 2001; 22: 1515-23.
7. Jie YH, Cammisuli S, Baggiolini M. Imunomodulatory effects of Panax ginseng in the mouse. Agent Actions 1984; 15: 386-91.
8. Sonoda Y, Kasahara T, Mukaida N. Stimulation of interleukin-8 production by acidic polysaccharides from the root of Panax ginseng. Immunopharmacology 1998; 38: 287-94.
9. Lee YS, Chung IS, Lee IR, et al. Activation of multiple effector pathways of immune system by the anti-neoplastic immunostimulator, acidic polysaccharide ginseng isolated from panax ginseng. Anticancer Res 1997; 17: 323-32.
10. Tomoda M, Hirabayashi K, Shimizu N, et al. Characterization of two novel polysaccharides having immunological activities from the root of panax ginseng. Biol Pharm Bull 1993; 16: 1087-90.
11. Shin KS, Kiyohara H, Matusmoto T, Yamada H. Rhamnogalacturonan II from the leaves of panax ginseng as macrophage Fc receptor expression-enhancing polysaccharide. Carbohydr Res 1997; 300: 239-49.
12. Scaglione F, Ferrara F, Dugnani S, et al. Immunomodulatory effects of two extracts of panax ginseng. Exp Clin Res 1990; 16: 537-42.
13. Kim KH, Lee YS, Jung IS, et al. Acidic polysaccharide from panax ginseng, ginsan, induces Th1 cells and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med 1998; 164: 110-5.
14. Wang M, Guilbert LJ, Li J, et al. A proprietary extract from North American ginseng ( Panax quinquefolius ) enhances IL-2 and IFN-g productions in murine spleen cells induced by Con-A. Int Immunopharmacol 2004; 4: 311-5.
15. Song JY, Han SK, Son EH, et al. Induction of secretory and tumoricidal activities in peripheral macrophages by ginsan. Int Immunopharmacol 2002; 2: 857-65.
16. Ma L, Zhou ZL, Yang Q. Study on effect of polysaccharides of ginseng on peripheral blood mononuclear cell induced interleukin-2 production and activity of its receptors in vitro. Chung Kuo Chung His Chien Ho Tsa Chih 1995; 15: 411-3.
17. Lust JA, Bennett M, Kumar V. Lysis of FLD-3 Friend erythroleukemia cells in vitro and in vivo: effect of 89Sr treatment and Friend virus infection. Int J Cancer 1984; 33: 107-13.
18. Iorio AM, Neri M, Zei T, et al. Natural resistance in mice against Friend leukemia cells II. Studies with in vivo passaged interferon-sensitive and interferon- resistant cell clones. Cell Immunol 1989; 118: 425-34.
19. Neri M, Zei T, Bonmassar E, et al. Natural resistance in mice against Friend cells injected intravenously. III. Comparison between in vivo and in vitro passaged interferon-sensitive (745) and interferon-resistant (3C18) cell clones. Br J Cancer 1989; 59: 848-53.
20. Gauwerky CE, Lusis AJ, Golde DW. Human leukemia cell line K452 responds to erythroid-potentiating activity. Blood 1982; 59: 300-5.
21. Werkmeister JA, Kelfand SL, Haliotis T, et al. The effect of target cell differentiation on human natural killer cell activity: a specifi c defect in target cell binding and early activation events. J Immunol 1982; 129: 413-8.
22. Kimber I, Moore M, Roberts K. Variance in resistance to natural and antibody-dependent cellular cytotoxicity and to complement-mediated lysis among K562 lines. Int J Cancer 1983; 32: 219-25.
23. Hagner G. Induction of erythroid differentiation in K562 cells and natural killer cell-mediated lysis: distinct effects at the level of recognition and lysis in relation to target cell proliferation. Immunobiology 1984; 167: 389-97.
24. Miller SC, Christopher FL, Dussault I. Population dynamics of natural killer cells and T lymphocytes in murine spleen and bone marrow during the development of erythroleukemia. Nat Immunol 1992; 11: 78-91.
25. Dussault I, Miller SC. Effect on leukemia cell numbers of in vivo administration of immunotherapeutic agents is age-dependent. Oncology 1996; 53: 241-6.
26. Dussault I, Miller SC. Suppression of natural killer cell activity in infant mice occurs after target cell binding. Nat Immunol 1995; 14: 35-43.
27. Sun LZY, Currier NL, Miller SC. The American conefl ower: a prophylactic role involving non-specifi c immunity. J Altern Comp Med 1999; 5: 437-46.
28. Miller SC. Age-related differences in the effect of in vivo administration of indomethacin on hemopoietic cell lineages of the spleen and bone marrow of mice. Experientia 1992; 48: 674-8.
29. Mahoney MX, Currier NL, Miller SC. Natural killer cell levels in older adult mice are gender-dependent: thyroxin is a gender-independent natural killer cell stimulant. Nat Immunol 1998; 16: 165-74.
30. Miller SC, Kearney SL. Effect of in vivo administration on the hemopoietic cell populations of the spleen and bone marrow: profound strain differences between A/J and C57Bl/6J mice. Lab Anim Sci 1997; 48: 74-80.
31. Currier NL, Miller SC. Natural killer cells from aging mice treated with extracts from Echinacea purpurea are quantitatively and functionally rejuvenated. Exp Gerontol 2000; 35: 627-39.
32. Kasai M, Iwamori M, Nagai Y, et al. A glycolipid on the surface of mouse natural killer cells. Eur J Immunol 1980; 10: 175-80.
33. Beck BN, Gillis S, Henney CS. Display of neutral glycolipid ganglio-N-tetrasylceramide (Asialo GM1) on cells of the natural killer and T lineages. Transplantation 1982; 33: 118-22.
34. Brittenden J, Heys SD, Ross J, et al. Natural killer cells and cancer. Cancer 1996; 77: 1226-43.
35. Koo GC, Cayre Y, Mittl LR. Comparative study of splenic natural killer cells and prothymocytes. Cell Immunol 1981; 62: 164-71.
36. Tam MR, Emmons SL, Pollack SB. Analysis and enrichment of murine natural killer cells with the fluorescence-activated cell sorter. J Immunol 1980; 124: 650-5.
37. Keissling R, Wigzell H. An analysis of the murine NK cells as to structure, function and biological relevance. Immunol Rev 1979; 44: 165-208.
38. Kiessling R, Klein E, Pross H, et al. "Natural" killer cells in the mouse. II. Cytotoxic cells with specifi city for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 1975; 5: 117-21.
39. Togola A, Inngjerdingen M, Diallo D, et al. Polysaccharides with complement fi xing and macrophage stimulation activity from Opilia celtidifolia isolation and partial characterisation. J Ethnopharmacol 2007; 115: 423-31.
40. Murai M, Aramaki Y, Tsuchiya S. a2-Macroglobulin stimulation of protein tyrosine phosphorylation in macrophages via the mannose receptor for FcY receptor-mediated phagocytosis activation. Immunology 2003; 89: 436-41.
41. Sharon N. Surface carbohydrates and surface lectins are recognition determinants in phagocytosis. Immunol Today 1984; 5: 143-8.
42. Nagamura Y, Kolb H. Presence of a lectin-like receptor for D-galactose on rat peritoneal macrophages. FEBS Lett 1980; 115: 59-62.